Related Experiment Videos
Embryo freezing after intracytoplasmic sperm injection.
E Van den Abbeel1, M Camus, H Joris
1Centre for Reproductive Medicine, University Hospital, Dutch-speaking Brussels, Free University, Belgium. livfvale@az.vub.ae.be
Molecular and Cellular Endocrinology
|January 13, 2001
Summary
Cryopreservation of human embryos after intracytoplasmic sperm injection (ICSI) shows potential safety, but 40% survival rates and significant pregnancy loss warrant further investigation for improved efficiency.
Area of Science:
- Reproductive Medicine
- Embryology
- Cryobiology
Background:
- Intracytoplasmic sperm injection (ICSI) is a common assisted reproductive technology.
- Cryopreservation of human embryos is crucial for optimizing IVF cycles.
- Assessing the safety and efficiency of ICSI embryo cryopreservation is essential.
Purpose of the Study:
- To evaluate the safety and efficiency of cryopreservation for human embryos generated via ICSI.
- To assess embryo survival rates, developmental capacity post-thaw, and clinical outcomes.
- To determine the live birth rate following the transfer of cryopreserved ICSI embryos.
Main Methods:
- Human embryos obtained from ICSI procedures were cryopreserved.
- Morphological survival and in vitro/in vivo developmental potential of thawed embryos were assessed.
- Clinical outcomes, including pregnancy loss and live birth rates, were analyzed.
Main Results:
- 40% of embryos did not survive the cryopreservation and thawing process.
- Pregnancy loss rate was 31% (13% subclinical, 18% miscarriage) after selective embryo transfer.
- Live birth rates were 7% per transferred embryo and 3% per thawed embryo.
Conclusions:
- Cryopreservation of ICSI embryos appears to be a safe procedure based on obstetric outcomes and initial child follow-up.
- Further long-term follow-up of children born from cryopreserved ICSI embryos is necessary.
- Improving embryo survival and developmental potential post-cryopreservation is critical for enhancing efficiency.